Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan · Delayed Price · Currency is TWD 48.00
-2.60 (-5.14%)
At close: Mar 3, 2026
TPE:6657 Market Cap
TPE:6657 has a market cap or net worth of 4.26 billion as of March 3, 2026. Its market cap has increased by 3.20% in one year.
Market Cap
4.26B
Enterprise Value
3.35B
Revenue
7.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.00
Market Cap Chart
Since August 8, 2018, TPE:6657's market cap has increased from 1.02B to 4.26B, an increase of 315.99%. That is a compound annual growth rate of 20.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 4.49B | 17.67% |
| Dec 31, 2025 | 3.81B | -1.55% |
| Dec 31, 2024 | 3.87B | -15.67% |
| Dec 29, 2023 | 4.59B | 60.69% |
| Dec 30, 2022 | 2.86B | -4.64% |
| Dec 30, 2021 | 3.00B | 2.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UnicoCell Biomed | 5.22B |
| Pharmosa Biopharm | 5.17B |
| BioGend Therapeutics | 4.58B |
| Senhwa Biosciences | 4.48B |
| Formosa Pharmaceuticals | 4.25B |
| Medigen Biotechnology | 4.20B |
| Intech Biopharm | 3.89B |
| ACRO Biomedical | 3.89B |